# OR5AS1

## Overview
OR5AS1 is a gene that encodes the protein olfactory receptor family 5 subfamily AS member 1, which is part of the G-protein-coupled receptor (GPCR) superfamily. These receptors are primarily involved in the detection of odor molecules, playing a crucial role in the sense of smell. The protein encoded by OR5AS1 is a transmembrane receptor, characterized by its seven-transmembrane domain structure typical of GPCRs, which facilitates signal transduction across the cell membrane. While primarily associated with olfactory functions, emerging research suggests that OR5AS1 may have broader implications in various physiological and pathological processes, including its potential involvement in melanoma and neurodegenerative diseases (Biradar2020Identification; Rabin2009Sporadic).

## Clinical Significance
The OR5AS1 gene, part of the olfactory receptor family, has been implicated in various diseases and conditions through mutations and alterations in its expression. In the context of melanoma, a study by Biradar et al. identified OR5AS1 as one of the genes potentially involved in the transformation of normal skin epithelial cells into melanoma cells. This suggests that OR5AS1 could serve as a potential biomarker for melanoma diagnosis and therapeutic purposes, although further validation is needed (Biradar2020Identification).

In the realm of neurodegenerative diseases, OR5AS1 was identified in a study on sporadic amyotrophic lateral sclerosis (ALS). The study focused on aberrant splicing and gene expression in motor neurons, highlighting the significance of aberrant splicing in ALS pathogenesis. However, the specific clinical significance of OR5AS1 mutations or expression alterations in ALS remains unclear (Rabin2009Sporadic).

Overall, while OR5AS1 has been associated with certain conditions, its precise role and clinical significance require further investigation to establish its potential as a diagnostic or therapeutic target.


## References


[1. (Biradar2020Identification) Shivaleela Biradar, K. M. Kiran Kumar, M. Naveen Kumar, and R. L. Babu. Identification of Clinical Variants Present in Skin Melanoma Using Exome Sequencing Data, pages 85–96. Springer International Publishing, 2020. URL: http://dx.doi.org/10.1007/978-3-030-46943-6_10, doi:10.1007/978-3-030-46943-6_10. This article has 0 citations.](https://doi.org/10.1007/978-3-030-46943-6_10)

[2. (Rabin2009Sporadic) Stuart J. Rabin, Jae Mun ‘Hugo’ Kim, Michael Baughn, Ryan T. Libby, Young Joo Kim, Yuxin Fan, Randell T. Libby, Albert La Spada, Brad Stone, and John Ravits. Sporadic als has compartment-specific aberrant exon splicing and altered cell–matrix adhesion biology. Human Molecular Genetics, 19(2):313–328, November 2009. URL: http://dx.doi.org/10.1093/hmg/ddp498, doi:10.1093/hmg/ddp498. This article has 112 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp498)